SEC Form D · filed August 24, 2022
DMC Biotechnologies, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Doug D. Cameron · Boulder, CODirectorRob D. Van Der Meij · Boulder, CODirectorMatthew L. Lipscomb · Boulder, COExec · DirectorAlastair D. Cooper · Boulder, CODirectorMichael D. Lynch · Boulder, CODirectorJosko D. Bobanovic · Boulder, CODirectorCarolyn D. Fritz · Boulder, CODirectorHarlan M. Peltz · Los Angeles, CADirectorCarla R. Hartzenberg · Vancouver, British Columbia, CanadaDirectorKelly Watters · Telluride, CODirectorJoseph G. Machado · Boston, MADirectorJames F. Oliviero, Iii · Waltham, MADirectorBrian M. Good · Los Angeles, CADirectorAndrew M. Peltz · Los Angeles, CAExec · DirectorAshley D. Jenkins · Boulder, COExecRonghui Gu · New York, NYDirectorZhong Shao · New York, NYDirectorMuhan Zou · New York, NYExec · DirectorManivannan Shanmugam · Frisco, TXDirectorBryan A. Helmkamp · New York, NYDirectorLarry N. Feinberg · GREENWICH, CTDirectorDarell L. Krasnoff · LOS ANGELES, CADirectorAshley D. Jenkins · Boulder, COExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗